South Florida pharmaceutical firm doubles down on niche drug market
(WorldNews Business)

As the market for drugs aimed at treating rare diseases continues to grow, South Florida`s biotechnology companies and pharmaceutical firms are getting in on the action. Jupiter Orphan Therapeutics is the latest in the region to receive `orphan` drug designation from the U.S. Food and Drug Administration for a product, a major milestone in the path to bringing new medicines to market. (Phillip Frost`s Opko Health is another major player in the niche industry segment.) Orphan drugs are those that... ......